Investment analysts at StockNews.com began coverage on shares of OpGen (NASDAQ:OPGN – Get Free Report) in a research report issued on Monday. The firm set a “sell” rating on the medical research company’s stock.
OpGen Stock Up 2.5 %
Shares of NASDAQ OPGN opened at $0.61 on Monday. OpGen has a 52 week low of $0.17 and a 52 week high of $3.84. The business has a 50-day simple moving average of $0.57 and a two-hundred day simple moving average of $0.51. The company has a market cap of $7.74 million, a P/E ratio of -0.09 and a beta of -0.71.
OpGen Company Profile
Featured Stories
- Five stocks we like better than OpGen
- The How and Why of Investing in Gold Stocks
- Charles Schwab Fortifies its Uptrend on EPS Beat
- Investing in large cap stocks: Diving into big caps
- Lockheed Martin Stock Aims for a Fresh All-Time High
- Investing in Commodities: What Are They? How to Invest in Them
- Beyond the Halving: The Future of Bitcoin Mining Stocks
Receive News & Ratings for OpGen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OpGen and related companies with MarketBeat.com's FREE daily email newsletter.